Back

Concurrent light chain and transthyretin cardiac amyloidosis.

27 August 2022 (11:48 - 12:01)
Organised by:
Congress Presentation Part of: Amyloidosis: diagnosis and management Clinical ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christopher Kanaan

Mayo Clinic Hospital, Phoenix (United States of America)

4 More presentations in this session

Presentation thumbnail
Amyloidosis: diagnosis and management - Get ready for the session.
Slides Video
Presentation thumbnail
First degree atrioventricular block as an early predictor of advanced conduction system disease in Val 142Ile hereditary cardiac amiloydosis.
Doctor N. S V Nunes (Niteroi, BR)
Slides Video
Presentation thumbnail
Two rare conditions on the same patient: AL cardiac amyloidosis in a female carrier of ATTR mutation (pval142ile) with a family history of heart failure at a young age.
Associate Professor F. Guerra (Ancona, IT)
Slides Video
Presentation thumbnail
The successful treatment of a cardiogenic shock due to cardiac light chain (AL) amyloidosis.
Doctor M. Fialova (Hradec Kralove, CZ)
Slides Video

Access the full session

Session thumbnail
Amyloidosis: diagnosis and management
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 11:48 CET
You may be interested in
thumbnail
Congress Session
Challenges in cardiac amyloidosis
29 August 2025
thumbnail
Congress Presentation
The correct diagnosis in this case, and why
25 August 2023
thumbnail
Congress Presentation
Cardiac amyloidosis: clinical clues and diagnostic dilemmas – insights from Ireland
26 August 2023
thumbnail
Congress Presentation
Concurrent light chain and transthyretin cardiac amyloidosis
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources